Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Concurrent Montelukast and Bepotastine in Healthy Adults
NCT04097951Phase 1Unknown
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast and bepotastine in allergic rhinitis (AR) and asthma (3 arms), sponsored by Hyundai Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetic Assessment at 24 hours. Status: unknown.
02
Drugs
montelukastbepotastine
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on NCT04097951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097951.